Dexcom | DXCM - 流动负债

金融业

USD 82.29

USD 6.24B

现金及等价物

USD 961.4M

USD 478.4M

USD 3.92B

USD 2.25B

USD 1.24B

USD 318.3M

USD 435.2M

10.3K

EPS每股收益

USD 0.73

股本和储备

USD 2.54B

USD 864.4M

债务利息支出

USD 3.1M

USD 16.9M

USD 1.3B

USD 33.11B

USD 249.1M

USD 990.1M

USD 318.3M

普通股股本

USD 377.4M

31.31

USD 317.5M

USD 1.34B

销售和管理费用

USD 358.7M

USD 770.7M

贸易债权人

USD 2.08B

应收帐款人

USD 1.27B

	流动负债	更改		日
Abbott	USD 18.38B		1.88B	2026-03
Align Technology	USD 1.91B		4.9M	2026-09
AtriCure	USD 81.92M		8.72M	2026-06
Baxter International	USD 3.81B		218M	2026-09
Becton, Dickinson and Co.	USD 9.4B		897M	2026-06
Boston Scientific	USD 6.43B		1.86B	2026-06
Cooper Companies	USD 1.87B		61.9M	2026-06
Dexcom	USD 2.25B		105.1M	2026-09
Edwards Lifesciences	USD 1.51B		98.9M	2026-06
Globus Medical	USD 479.35M		3.12M	2026-06
Inogen	USD 64.94M		2.12M	2025-09
Insulet	USD 744.2M		56.7M	2026-06
Integra LifeSciences	USD 329M		1.88M	2026-09
J&J	USD 55.46B		562M	2026-09
Medtronic	USD 11.8B		141M	2026-06
Merit Medical Systems	USD 265.08M		150K	2026-09
Roche Holding	CHF 28.85B		846M	2026-06
Solventum Corp	USD 3.66B		317M	2026-06
Stryker	USD 6.5B		184M	2026-09
Tandem Diabetes Care	USD 253M		5.05M	2026-06
Teleflex	USD 720.38M		7.67M	2026-06
West Pharmaceutical Services	USD 644.3M		3.8M	2026-09
Zimmer Biomet Holdings	USD 3.01B		149.2M	2026-06